Emerging as a promising avenue for managing the debilitating effects of Chronic Sclerosis, stem cell therapy is steadily gaining attention within the neurological field. While not a resolution, this groundbreaking approach aims to regenerate damaged myelin sheaths and reduce neurological decline. Several clinical trials are currently mesenchymal st